en.unionpedia.org

Milacemide, the Glossary

Index Milacemide

Milacemide (INN) is an MAO-B inhibitor and glycine prodrug.[1]

Table of Contents

  1. 7 relations: Alzheimer's disease, Amino acid, Glycine, International nonproprietary name, Monoamine oxidase B, Prodrug, Tricine.

  2. NMDA receptor agonists
  3. Pentyl compounds

Alzheimer's disease

Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens, and is the cause of 60–70% of cases of dementia.

See Milacemide and Alzheimer's disease

Amino acid

Amino acids are organic compounds that contain both amino and carboxylic acid functional groups.

See Milacemide and Amino acid

Glycine

Glycine (symbol Gly or G) is an amino acid that has a single hydrogen atom as its side chain. Milacemide and Glycine are Glycine receptor agonists and NMDA receptor agonists.

See Milacemide and Glycine

International nonproprietary name

An international nonproprietary name (INN) is an official generic and nonproprietary name given to a pharmaceutical drug or an active ingredient.

See Milacemide and International nonproprietary name

Monoamine oxidase B

Monoamine oxidase B, also known as MAO-B, is an enzyme that in humans is encoded by the MAOB gene.

See Milacemide and Monoamine oxidase B

Prodrug

A prodrug is a pharmacologically inactive medication or compound that, after intake, is metabolized (i.e., converted within the body) into a pharmacologically active drug. Milacemide and prodrug are prodrugs.

See Milacemide and Prodrug

Tricine

Tricine is an organic compound that is used in buffer solutions. Milacemide and Tricine are amino acid derivatives.

See Milacemide and Tricine

See also

NMDA receptor agonists

Pentyl compounds

References

[1] https://en.wikipedia.org/wiki/Milacemide

Also known as C7H16N2O, Pentylglycinamide.